Overview
- Live Action published recordings of calls to 27 Planned Parenthood locations in which staff described access to abortion pills via telehealth without ultrasounds, confidential shipping including to alternate addresses, and in some cases no Rh testing or follow-up.
- One call captured a staffer in Brooklyn Park, Minnesota stating that ending the pregnancy would be safer than carrying to term.
- In a letter to HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, the group pressed for suspending mifepristone, prohibiting mail and telehealth distribution, and restoring full adverse-event reporting, citing an EPPC analysis that claims higher complication rates.
- Planned Parenthood responded that its health centers comply with laws and clinical standards and reiterated that mifepristone is safe and widely used.
- FDA Commissioner Marty Makary said a comprehensive review is underway in the data-acquisition phase, as Live Action unveiled its materials at a Capitol Hill event with Republican lawmakers ahead of the March for Life.